263 related articles for article (PubMed ID: 19070516)
1. The impact of race on prostate cancer detection and choice of treatment in men undergoing a contemporary extended biopsy approach.
Swords K; Wallen EM; Pruthi RS
Urol Oncol; 2010; 28(3):280-4. PubMed ID: 19070516
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
[TBL] [Abstract][Full Text] [Related]
3. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
Yanke BV; Carver BS; Bianco FJ; Simoneaux WJ; Venable DD; Powell IJ; Eastham JA
BJU Int; 2006 Oct; 98(4):783-7. PubMed ID: 16978273
[TBL] [Abstract][Full Text] [Related]
4. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
5. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
Latchamsetty KC; Kim J; Porter CR
J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical and pathological features in African-American and Caucasian patients with localized prostate cancer.
Kang JS; Maygarden SJ; Mohler JL; Pruthi RS
BJU Int; 2004 Jun; 93(9):1207-10. PubMed ID: 15180606
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
Lam JS; Cheung YK; Benson MC; Goluboff ET
J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
[TBL] [Abstract][Full Text] [Related]
10. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
Porter CR; Kim J
Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
12. African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.
Kryvenko ON; Balise R; Soodana Prakash N; Epstein JI
J Urol; 2016 Feb; 195(2):301-6. PubMed ID: 26341575
[TBL] [Abstract][Full Text] [Related]
13. Serum testosterone levels in African-American and white men undergoing prostate biopsy.
Kubricht WS; Williams BJ; Whatley T; Pinckard P; Eastham JA
Urology; 1999 Dec; 54(6):1035-8. PubMed ID: 10604704
[TBL] [Abstract][Full Text] [Related]
14. The impact of African American race on prostate cancer detection on repeat prostate biopsy in a veteran population.
Sterling WA; Weiner J; Schreiber D; Mehta K; Weiss JP
Int Urol Nephrol; 2016 Dec; 48(12):2015-2021. PubMed ID: 27580731
[TBL] [Abstract][Full Text] [Related]
15. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
Abdalla I; Ray P; Vaida F; Vijayakumar S
Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
[TBL] [Abstract][Full Text] [Related]
17. A Population-Based Study of Men With Low-Volume Low-Risk Prostate Cancer: Does African-American Race Predict for More Aggressive Disease?
Schreiber D; Chhabra A; Rineer J; Weedon J; Schwartz D
Clin Genitourin Cancer; 2015 Aug; 13(4):e259-e264. PubMed ID: 25777681
[TBL] [Abstract][Full Text] [Related]
18. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
Schenk JM; Newcomb LF; Zheng Y; Faino AV; Zhu K; Nyame YA; Brooks JD; Carroll PR; Cooperberg MR; Dash A; Filson CP; Gleave ME; Liss M; Martin FM; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW
J Urol; 2020 Apr; 203(4):727-733. PubMed ID: 31651227
[TBL] [Abstract][Full Text] [Related]
19. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates.
Pan CC; Lee JS; Chan JL; Sandler HM; Underwood W; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1292-6. PubMed ID: 14630264
[TBL] [Abstract][Full Text] [Related]
20. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.
Saltzman AF; Luo S; Scherrer JF; Carson KD; Grubb RL; Hudson MA
Urol Oncol; 2015 Jul; 33(7):330.e9-17. PubMed ID: 25937424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]